MedPath

Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients

Not Applicable
Conditions
Alzheimer Disease
Depression
Interventions
Device: high-density electroencephalography
Registration Number
NCT02840045
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The purpose of this study is to use a new method to differentiate mnesic abilities of early alzheimer patients and patients with a depressive disorder.

This method is based on the recording of cerebral activity while patients listen to familiar, unfamiliar and newly-learned music.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Being right-handed
  • recorded consent
  • For Alzheimer patients: Mini Mental Status Examination (MMSE) score >= 18
  • For patients with a depressive disorder : Major Depressive Disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM IV) and Montgomery-Asberg depression rating scale (MADRS) score >= 25
  • For healthy controls : no cognitive deficit, MADRS score < 25, no depressive disorder according to DSM IV
Exclusion Criteria
  • Auditory deficit
  • contraindication to a high-density electroencephalography exam
  • refusal to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Healthy controlshigh-density electroencephalographyCerebral measurements from high-density electroencephalography are recorded in healthy controls
Alzheimer patientshigh-density electroencephalographyCerebral measurements from high-density electroencephalography are recorded in Alzheimer patients. The same protocol is applied in the 3 arms
patients with a depressive disorderhigh-density electroencephalographyCerebral measurements from high-density electroencephalography are recorded in patients with a depressive disorder. The same protocol is applied in the 3 arms
Primary Outcome Measures
NameTimeMethod
Amplitude of event-related potentialsday 1 for familiar and unfamiliar songs and day 14 for newly learned songs

Measurements of the amplitude of event-related potentials with electroencephalography at day one for familiar and unfamiliar songs and after 2 weeks for newly learned songs

Secondary Outcome Measures
NameTimeMethod
Spectral powerday 1 for familiar and unfamiliar songs and day 14 for newly learned songs

Measurements of the spectral power with electroencephalography at day one for familiar and unfamiliar songs and after 2 weeks for newly learned songs

Trial Locations

Locations (1)

CHRU Besançon

🇫🇷

Besancon, Franche-Comte, France

© Copyright 2025. All Rights Reserved by MedPath